Development of a tissue-engineering vascular graft for use in wcongenital heart surgery

EBioMedicine

Volumn 1, Issue 1, 2014, Pages 12-13

  Shinoka, Toshiharu ^a,b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

BIODEGRADABILITY; BIRTH DEFECT; BLOOD VESSEL GRAFT; BONE MARROW DERIVED MONONUCLEAR CELL; CONGENITAL HEART DISEASE; ELECTROSPINNING; HEART VALVE REPLACEMENT; HUMAN; MORBIDITY; MORTALITY; NOTE; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE SCAFFOLD;

EID: 84921964678     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2014.10.001     Document Type: Note

References (6)

1. de Mel, A., Punshon, G., Ramesh, B., et al., 2009. In situ endothelialization potential of a biofunctionalised nanocomposite biomaterial-based small diameter bypass graft. Biomed. Mater. Eng. 19 (4-5), 317-331.
2. Hibino, N., McGillicuddy, E., Matsumura, G., et al., 2010. Late-term results of tissueengineered vascular grafts in humans. J. Thorac. Cardiovasc. Surg. 139, 431-436.
3. Hibino, N., Villalona, G., Pietris, N., et al., 2011. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. FASEB J. 25, 2731-2739.
4. Olausson, M., Patil, P.B., Kuna, V.K., Chougule, P., Hernandez, N., Methe, K., Kullberg-Lindh, C., Borg, H., Ejnell, H., Sumitran-Holgersson, S., 2012. Transplantation of an allogenic vein bioengineered with autologous stem cells: a proof-of-concept study. Lancet 380, 230-237.
5. Shinoka, T., Imai, Y., Ikada, Y., 2001. Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 344, 532-533.
6. Thomas, L.V., Nair, P.D., 2013. The effect of pulsatile loading and scaffold structure for the generation of a medial equivalent tissue engineered vascular graft. Biores. Open Access 2 (3), 227-239.